ArticleOncogenesis2018

Effectiveness of EGFR/HER2-targeted drugs is influenced by the downstream interaction shifts of PTPIP51 in HER2-amplified breast cancer cells.

Eric Dietel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.